Ranok Therapeutics
Ranok Therapeutics uses of chaperone-mediated protein degraders (CHAMPs) against BRD4, a transcription factor that is implicated in cancer development.
B2X
0
Company Operating Status
Active
Country
Email Address
bd@ranoktherapeutics.com
0
jobs@ranoktherapeutics.com
0
Founded Date
2018
Founder
Full Address
303 Wyman Street, Suite 300 Waltham, MA 02451
0
Suite 1005, Building 1 501 2nd Avenue Qiantang New District, Hangzhou 310018
0
Headquarters
Investors
Latest Funding Round Date
August 19, 2021
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
11 – 50
0
Pitchbook URL
Total Funding Amount (USD)
40,000,000
Twitter URL
Official Website
Find more companies like Ranok Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
